(Q39539382)

12 September 2017

The effect of methylated oligonucleotide targeting Ki-67 gene in human 786-0 renal carcinoma cells (English)

1 reference

12 September 2017

1 reference

Xue-Qin Li

1

1 reference

12 September 2017

Dong-Sheng Pei

2

1 reference

12 September 2017

Guo-Wei Qian

3

1 reference

12 September 2017

Xiao-Xing Yin

4

1 reference

12 September 2017

Qian Cheng

5

1 reference

12 September 2017

Lian-Tao Li

6

1 reference

12 September 2017

Hui-Zhong Li

7

1 reference

12 September 2017

Jun-Nian Zheng

8

1 reference

12 September 2017

20 May 2011

1 reference

12 September 2017

1 reference

12 September 2017

32

1 reference

12 September 2017

5

1 reference

12 September 2017

863-872

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-011-0187-0

12 September 2017

0 references

cites work

Management of metastatic renal cell carcinoma: current trends

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0187-0

Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0187-0

Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0187-0

The Ki-67 protein: fascinating forms and an unknown function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0187-0

Anti-Ki-67 peptide nucleic acid affects the proliferation and apoptosis of human renal carcinoma cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0187-0

Knockdown of Ki-67 by small interfering RNA leads to inhibition of proliferation and induction of apoptosis in human renal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0187-0

DNA methylation: an alternative pathway to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0187-0

The history of cancer epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0187-0

Stability of patch methylation and its impact in regions of transcriptional initiation and elongation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0187-0

A methylated oligonucleotide inhibits IGF2 expression and enhances survival in a model of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0187-0

Epigenetic therapy of cancer: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0187-0

The role of parental and grandparental epigenetic alterations in familial cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0187-0

Comprehensive analysis of CpG islands in human chromosomes 21 and 22

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0187-0

Cyclical DNA methylation of a transcriptionally active promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0187-0

A novel CpG island set identifies tissue-specific methylation at developmental gene loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0187-0

Methylation-induced repression--belts, braces, and chromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0187-0

A methylated oligonucleotide induced methylation of GSTP1 promoter and suppressed its expression in A549 lung adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0187-0

Induction of apoptosis of non-small cell lung cancer by a methylated oligonucleotide targeting survivin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0187-0

Induced epigenetic modifications of the promoter chromatin silence survivin and inhibit tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0187-0

Inhibition of Ki-67 in a renal cell carcinoma severe combined immunodeficiency disease mouse model is associated with induction of apoptosis and tumour growth inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0187-0

Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0187-0

DNA Methylation and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-011-0187-0

Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma

21 January 2018

1 reference

12 December 2020

Biochemical characterization of pKi67 with the identification of a mitotic-specific form associated with hyperphosphorylation and altered DNA binding

1 reference

12 December 2020

Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67

1 reference

12 December 2020

Antisense treatment against Ki‐67 mRNA inhibits proliferation and tumor growth in vitro and in vivo

1 reference

12 December 2020

Posttranslational modifications of the KI-67 protein coincide with two major checkpoints during mitosis

1 reference

12 December 2020

10.1007/S13277-011-0187-0

Identifiers

DOI

1 reference

12 September 2017

1 reference